Clinical Trials
46 trialsSequential Targeting of Cluster of Differentiation 52 (CD52) and Tumor Necrosis Factor (TNF) Allows Early Minimization Therapy in Kidney Transplantation
Institute for Clinical and Experimental Medicine
Turkish Version of the UCLA Prostate Cancer Index
Lokman Hekim University
TURBT
Dr. Lutfi Kirdar Kartal Training and Research Hospital
Comparison of Pathological Outcome and Recurrence Rate Between En Bloc and Conventional Transurethral Resection of Bladder Tumor
Lahore General Hospital
Neoadjuvant Toripalimab in Combination With Gemcitabine Therapy in Cisplatin Ineligible Local Advanved Bladder Cancer
Henan Cancer Hospital
INSTIN
Institut National de la Santé Et de la Recherche Médicale, France
TRUS
Ankara Etlik City Hospital
ARPC-MRI
East and North Hertfordshire NHS Trust
The Effects of Acupuncture and the Therapist´s Communication on Chemotherapy Induced Nausea and Vomiting
Västernorrland County Council, Sweden
Primary Prostatic Lymphoma on a 66 Year-old Male in Mexico.
Instituto Mexicano del Seguro Social
KEEPER
Azienda USL Reggio Emilia - IRCCS
PCa_LS
Azienda USL Reggio Emilia - IRCCS
IEPBR
Ankara Etlik City Hospital
A Diagnostic Prediction Model for Prostate Cancer in Patients With PI-RADS Score 3
Anhui Provincial Hospital
HIFU-PRO
Turku University Hospital
IMNR
Dr. Lutfi Kirdar Kartal Training and Research Hospital
CETOREIN
University Hospital, Angers
ZiPUP
South Metropolitan Health Service
The Impact of Neoadjuvant Chemotherapy on Survival Outcomes in Patients With Variant Histologies Bladder Cancer Who Underwent Radical Cystectomy
Ankara Etlik City Hospital
ERUP
Hull University Teaching Hospitals NHS Trust
Peroperative Fluid Management in Major Gynecological Cancer Surgeries
Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Aromatherapy on Pain and Anxiety of the Patients Undergoing Prostate Biopsy
Mersin Training and Research Hospital
Risk-adapted Strategy Including Magnetic Resonance Imaging and Prostate-specific Antigen Density in Blood for Biopsy Decision in Patients With Lesions Suspicious for Prostate Cancer
Ankara Etlik City Hospital
The Effectiveness and Safety of Neoadjuvant Intravesical Mitomycin-C Instillation
National Cancer Center, Korea
PCa_Ex
Azienda USL Reggio Emilia - IRCCS
PROSTAGE
Turku University Hospital
High-power Green-light Laser Endoscopic Submucosal Dissection for Non-muscle-invasive Bladder Cancer
Shandong Provincial Hospital
Study of Gemcitabine, Carboplatin and VELIPARIB (ABT-888) in Refractory Testicular Germ Cell Cancer
National Cancer Institute, Slovakia
Treatment of Recurrent Bladder Cancer With Dendritic Cells
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
MIB
Turku University Hospital
Anorectal Application of 5% Lidocaine Cream Reduces Pain Prior to Periprostatic Nerve Block During Transrectal Ultrasound Guided Biopsy
Assaf-Harofeh Medical Center
TransTuFo
Hull University Teaching Hospitals NHS Trust
Explaining the Invisible Using the PEARL System
Hull University Teaching Hospitals NHS Trust
Prevention of Micro-architectural Bone Decay in Males With Non-metastatic Prostate Cancer Receiving Androgen Deprivation Therapy (ADT)
Austin Health
Zinc/PSA Ratio as a Novel Biomarker for Prostate Cancer Detection
Bagcilar Training and Research Hospital
Avelumab in Refractory Testicular Germ Cell Cancer.
National Cancer Institute, Slovakia
Does End-fire Technique Increase Detection Rate of Prostate Cancer at First Re-biopsy Compared to Side-fire Technique?
Kronoberg County Council
ACEBIB
Turku University Hospital
Multi-IMPROD
Turku University Hospital
PROMANEG
Turku University Hospital
Pain Comparison Whit Visual Analog Scale (EVA) Between Four Analgesic Methods During Trans Rectal Prostatic Biopsy
Instituto Mexicano del Seguro Social
Impact of Local Anesthesia Type on Cancer Detection Rate in Transrectal Ultrasound Guided Prostate Biopsy
Bagcilar Training and Research Hospital
Flucipro
Turku University Hospital
IMPROD
Turku University Hospital
PallRad1
Sorlandet Hospital HF
Study on Evaluation of Zoledronic Acid to Prevent Bone Loss in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
Hospital Authority, Hong Kong